Insider Transactions in Q4 2020 at Oncocyte Corp (OCX)
Insider Transaction List (Q4 2020)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 28
2020
|
Alfred D Kingsley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
65,271
+14.52%
|
$65,271
$1.34 P/Share
|
Dec 23
2020
|
Alfred D Kingsley Director |
SELL
Open market or private sale
|
Direct |
900
-0.28%
|
$1,800
$2.55 P/Share
|
Dec 23
2020
|
Alfred D Kingsley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,237
+0.39%
|
$1,237
$1.34 P/Share
|
Dec 22
2020
|
Alfred D Kingsley Director |
SELL
Open market or private sale
|
Direct |
7,652
-2.35%
|
-
|
Dec 22
2020
|
Alfred D Kingsley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,516
+3.12%
|
$10,516
$1.34 P/Share
|
Dec 21
2020
|
Alfred D Kingsley Director |
SELL
Open market or private sale
|
Direct |
35,148
-5.08%
|
$70,296
$2.54 P/Share
|
Dec 21
2020
|
Alfred D Kingsley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
47,976
+12.03%
|
$47,976
$1.34 P/Share
|
Dec 11
2020
|
Mitchell S Levine Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,121
+17.81%
|
-
|
Dec 11
2020
|
Alfred D Kingsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,909
+1.91%
|
-
|
Dec 11
2020
|
Cavan M. Redmond Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,416
+20.63%
|
-
|
Dec 11
2020
|
Albert P Parker COO |
BUY
Grant, award, or other acquisition
|
Direct |
5,586
+34.54%
|
-
|
Dec 11
2020
|
Douglas T. Ross Former CSO |
BUY
Grant, award, or other acquisition
|
Direct |
5,317
+50.0%
|
-
|
Dec 11
2020
|
Padmavathi Sundar Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,177
+50.0%
|
-
|
Dec 11
2020
|
Andrew J. Last Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,184
+41.12%
|
-
|
Dec 11
2020
|
Andrew Arno Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,602
+7.89%
|
-
|
Dec 11
2020
|
Lyndal K. Hesterberg CSO |
BUY
Grant, award, or other acquisition
|
Direct |
6,603
+46.9%
|
-
|